Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimerism”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07599176
What this trial is testing

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Who this might be right for
Sickle Cell DiseaseBeta-thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 90
Not applicableStudy completedNCT00003196
What this trial is testing

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Looking for participantsNCT03707262
What this trial is testing

Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor

Who this might be right for
Renal Transplant RejectionToleranceKidney Transplant
Jeffrey Veale, MD 15
Testing effectiveness (Phase 2)Study completedNCT03663751
What this trial is testing

Low-dose Decitabine for the Treatment of Decreased Donor Chimerism After Allogeneic Stem Cell Transplantation

Who this might be right for
Response Rate
Shanghai Jiao Tong University School of Medicine 14
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Not applicableEnded earlyNCT00441779
What this trial is testing

Transfusion-Associated Microchimerism in Previously Injured Individuals Who Received a Blood Transfusion

Who this might be right for
ChimerismBlood TransfusionWounds and Injuries
National Heart, Lung, and Blood Institute (NHLBI) 59
Testing effectiveness (Phase 2)Study completedNCT01780454
What this trial is testing

Renal Allograft Tolerance Through Mixed Chimerism

Who this might be right for
End Stage Renal Disease
Massachusetts General Hospital 2
Large-scale testing (Phase 3)Study completedNCT01019876
What this trial is testing

Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureOsteopetrosisFanconi Anemia+1 more
Columbia University 38
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT03689907
What this trial is testing

Early Chimerism Following Allogeneic Stem-Cell Transplant

Who this might be right for
Allogeneic Stem-Cell Transplant
Dartmouth-Hitchcock Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT02029638
What this trial is testing

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

Who this might be right for
Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableUnknownNCT05905770
What this trial is testing

Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Early research (Phase 1)Active Not RecruitingNCT03249831
What this trial is testing

A Blood Stem Cell Transplant for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell DisorderHemoglobinopathies+2 more
City of Hope Medical Center 3
Early research (Phase 1)Looking for participantsNCT05757310
What this trial is testing

A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia

Who this might be right for
Recurrent Severe Aplastic AnemiaRefractory Severe Aplastic Anemia
City of Hope Medical Center 6
Not applicableUnknownNCT05200338
What this trial is testing

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Not applicableStudy completedNCT05249452
What this trial is testing

Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03077542
What this trial is testing

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 57
Early research (Phase 1)Study completedNCT00063817
What this trial is testing

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Who this might be right for
End-stage Renal DiseaseRenal TransplantationKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 5
Large-scale testing (Phase 3)Study completedNCT00176852
What this trial is testing

Stem Cell Transplant for Hemoglobinopathy

Who this might be right for
Sickle Cell DiseaseThalassemiaSevere Congenital Neutropenia+2 more
Masonic Cancer Center, University of Minnesota 22
Next Page